Becton, Dickinson and Company (BDX)

NYSE: BDX · Real-Time Price · USD

186.53

-1.58 (-0.84%)

At close: Oct 23, 2025, 4:00 PM EDT

186.53

0.00 (0.00%)

After-hours: Oct 23, 2025, 7:00 PM EDT

Revenue Breakdown

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2011 - 2020
Medication Delivery Solutions Revenue	4.52B	4.43B	Log In	Log In	Log In	Upgrade
Medication Management Solutions Revenue	3.44B	3.30B	Log In	Log In	Log In	Upgrade
Pharmaceutical Systems Revenue	2.30B	2.27B	Log In	Log In	Log In	Upgrade
Integrated Diagnostic Solutions Revenue	3.67B	3.68B	Log In	Log In	Log In	Upgrade
Biosciences Revenue	1.47B	1.51B	Log In	Log In	Log In	Upgrade
Surgery Revenue	1.54B	1.49B	Log In	Log In	Log In	Upgrade
Peripheral Intervention Revenue	1.97B	1.93B	Log In	Log In	Log In	Upgrade
Urology and Critical Care Revenue	1.60B	1.55B	Log In	Log In	Log In	Upgrade
Revenue (Other)	880.00M	9.00M	Log In	Log In	Log In	Upgrade
Revenue (Total)	21.39B	20.18B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2011 - 2020
Medical Revenue	11.14B	10.07B	Log In	Log In	Log In	Upgrade
Life Sciences Revenue	5.14B	5.19B	Log In	Log In	Log In	Upgrade
Interventional Revenue	5.11B	4.98B	Log In	Log In	Log In	Upgrade
Revenue (Total)	21.39B	20.18B	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2011 - 2020
Medical Operating Income	2.71B	2.74B	Log In	Log In	Log In	Upgrade
Life Sciences Operating Income	1.57B	1.60B	Log In	Log In	Log In	Upgrade
Interventional Operating Income	1.53B	1.42B	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-3.06B	-2.92B	Log In	Log In	Log In	Upgrade
Operating Income (Total)	2.75B	2.84B	Log In	Log In	Log In	Upgrade

Updated Aug 7, 2025. Data Source: Fiscal.ai.